Combined Evidence From Three Large British Association Studies Rejects TUCAN/CARD8 as an IBD Susceptibility Gene

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 2078-2080

  Fisher, Sheila A ^a   Mirza, Muddassar M ^a   Onnie, Clive M ^a   Soars, Dianne ^a   Lewis, Cathryn M ^a   Prescott, Natalie J ^a   Mathew, Christopher G ^a   Sanderson, Jeremy ^b   Forbes, Alastair ^c   Todhunter, Catherine ^d   Donaldson, Peter ^d   Mansfield, John ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARD8 PROTEIN; GENE PRODUCT; TUMOR UPREGULATED CARD CONTAINING ANTAGONIST OF CASPASE 9; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LETTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

EID: 34247609785     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.086     Document Type: Letter

References (9)

1. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203 (2001) 2473-2483
2. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
3. Hampe J., Cuthbert A., Croucher P.J.P., Mirza M.M., Mascheretti S., Fisher S., Frenzel H., King K., Hasselmeyer A., MacPherson A.J.S., Bridger S., van Deventer S., Forbes A., Nikolaus S., Lennard-Jones J.E., Foelsch U.R., Krawczak M., Lewis C., Schreiber S., and Mathew C.G. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
4. McGovern D.P., Butler H., Ahmad T., Paolucci M., van Heel D.A., Negoro K., Hysi P., Ragoussis J., Travis S.P., Cardon L.R., and Jewell D.P. TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 131 (2006) 1190-1196
5. Yamamoto M., Torigoe T., Kamiguchi K., Hirohashi Y., Nakanishi K., Nabeta C., Asanuma H., Tsuruma T., Sato T., Hata F., Ohmura T., Yamaguchi K., Kurotaki T., Hirata K., and Sato N. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis. Cancer Res 65 (2005) 8706-8714
6. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J.P., Mascheretti S., Sanderson J., Forbes A., Mansfield J., Schreiber S., Lewis C.M., and Mathew C.G. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 131 (2002) 1190-1196
7. Onnie C.M., Fisher S.A., Pattni R., Sanderson J., Forbes A., Lewis C.M., and Mathew C.F. Associations of allelic variants of the Multidrug Resistance Gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behaviour: a case-control study and meta-analysis. Inflamm Bowel Dis 12 (2006) 263-271
8. Hartland S., Newton J.L., Griffin S.M., and Donaldson P.T. A functional polymorphism in the Interleukin-1 receptor gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci 49 (2004) 1545-1550
9. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188